Page last updated: 2024-11-05

vigabatrin and Ischemia

vigabatrin has been researched along with Ischemia in 2 studies

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research Excerpts

ExcerptRelevanceReference
"A patient with focal epilepsy that was resistant to medical treatment received add-on therapy with vigabatrin."1.29[Allergic vasculitis caused by Vigabatrin]. ( Becker, EW; Berg, PA; Berkenfeld, R; Dieterle, L; Reinshagen, G, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, DS1
Kwak, SE1
Kim, JE1
Won, MH1
Kang, TC1
Dieterle, L1
Becker, EW1
Berg, PA1
Berkenfeld, R1
Reinshagen, G1

Other Studies

2 other studies available for vigabatrin and Ischemia

ArticleYear
The co-treatments of vigabatrin and P2X receptor antagonists protect ischemic neuronal cell death in the gerbil hippocampus.
    Brain research, 2006, Nov-20, Volume: 1120, Issue:1

    Topics: Adenosine Triphosphatases; Animals; Cell Death; Disease Models, Animal; Drug Therapy, Combination; E

2006
[Allergic vasculitis caused by Vigabatrin].
    Der Nervenarzt, 1994, Volume: 65, Issue:2

    Topics: Adult; Aminocaproates; Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedu

1994